Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-01

Clinical Trial Update: Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results for the pharmacokinetics (bioavailability) of 1-octanol in adults with ethanol-responsive essential tremor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 1-Octanol (octan-1-ol)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED | Results posted: 2012-02-01